These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 14658002

  • 1. Antiannexin V autoantibody in thrombophilic Behçet's disease.
    Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI.
    Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
    [Abstract] [Full Text] [Related]

  • 2. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?
    Priori R, Conti F, Pittoni V, Garofalo T, Sorice M, Valesini G.
    Thromb Haemost; 2000 Jan; 83(1):173-4. PubMed ID: 10669174
    [No Abstract] [Full Text] [Related]

  • 3. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G, Font J, Tàssies D, Vidaller A, Deulofeu R, López-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter JC.
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [Abstract] [Full Text] [Related]

  • 4. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
    Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin JH, Livneh A, Rosenberg N, Gelernter I, Gur H, Ehrenfeld M.
    Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Activated protein C resistance in Behçet disease].
    Guermazi S, M'Rad S, Lamloum M, Houman MH, Hamza M, Ben Dridi M, Miled M, Dellagi K.
    Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996
    [Abstract] [Full Text] [Related]

  • 10. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A, Ricart J, Todolí J, Micó L, Contreras T, Aznar J.
    Clin Hemorheol Microcirc; 2004 Dec; 30(3-4):411-4. PubMed ID: 15258375
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M.
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [Abstract] [Full Text] [Related]

  • 14. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapçioğlu G, Gümüşdiş G, Bayindir O, Doğanavşargil E.
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [Abstract] [Full Text] [Related]

  • 15. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A, Aksu K, Celik HA, Keser G, Cagirgan S, Omay SB, Inal V, Aydin HH, Tombuloglu M, Doganavsargil E.
    Thromb Res; 2005 Jun; 115(4):287-92. PubMed ID: 15668188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Jun; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.